Showing results (1381-1390 of 1,655) with videos related to

Sort By:
Pageof 166
American Heart Journal|May 16, 2016
Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trialJeffrey S Berger, Brian G Katona, W Schuyler Jones, et al.
The Annals of Thoracic Surgery|August 1, 1996
Twenty-year experience with repair of complete atrioventricular septal defectsJ S Tweddell, S B Litwin, S Berger, et al.
Scientific Reports|March 23, 2017
Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating GliomaLlewellyn E Jalbert, Adam Elkhaled, Joanna J Phillips, et al.
Cancers|November 27, 2021
Reply to Stummer, W.; Thomas, C. Comment on "Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)-Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540"Arthur Hosmann, Matthias Millesi, Lisa I Wadiura, et al.
Cancer Research Communications|April 8, 2022
Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade GliomaLucas A Salas, Thomas G Stewart, Bret C Mobley, et al.
Plos Pathogens|September 9, 2010
Surface co-expression of two different PfEMP1 antigens on single plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1Louise Joergensen, Dominique C Bengtsson, Anja Bengtsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 4, 2025
Platelet Activation and a Platelet Biosignature Are Associated With Cardiovascular Risk in Patients With Controlled PsoriasisMichael S Garshick, Kamelia Drenkova, Filipp Kazatsker, et al.
The New England Journal of Medicine|December 14, 2016
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery DiseaseWilliam R Hiatt, F Gerry R Fowkes, Gretchen Heizer, et al.
Journal of Vascular Surgery|October 3, 2024
Dynamic perioperative platelet activity and cardiovascular events in peripheral artery diseaseNatalie N Kennedy, Yuhe Xia, Tessa Barrett, et al.
Neuro-Oncology|March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrenceRadhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.
Pageof 166